About GammaTile

Driven to raise the standard of care and improve the lives of patients with brain tumors, a team of brain tumor specialists formed GT Medical Technologies. GammaTile Therapy is a Surgically Targeted Radiation Therapy (STaRT) for patients undergoing brain tumor removal surgery. GammaTile is FDA-cleared as a treatment for patients with newly diagnosed malignant intracranial neoplasms and patients with recurrent intracranial neoplasms. Since its full market release in the United States in March 2020, GammaTile has been offered in more than 100 hospitals, with more centers being added each month.

Products & Services

GammaTile is a bioresorbable collagen implant that delivers brain radiation – The only therapy on the market that provides immediate, effective, focused radiation to the brain tumor cavity at time of tumor removal to help eradicate residual tumor cells.

Questions?

Heather Murray
Call: 631-897-7387
Email: hmurray@gtmedtech.com

  • Hidden
  • This field is for validation purposes and should be left unchanged.